Trastuzumab: cardiotoxicity uncommon & generally reversible

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2010年 / 1311卷 / 1期
关键词：
Trastuzumab; Symptomatic Heart Failure; Severe Congestive Heart Failure; National Surgical Adjuvant Breast; Adjuvant Trastuzumab;
D O I：
10.2165/00128415-201013110-00005
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [31] Trastuzumab-Induced Cardiotoxicity: Is it a Personalized Risk?
    Milano, Gerard A.
    Serres, Emilie
    Ferrero, Jean-Marc
    Ciccolini, Joseph
    CURRENT DRUG TARGETS, 2014, 15 (13) : 1200 - 1204
  • [32] Cardiotoxicity Debated for Anthracyclines and Trastuzumab in Breast Cancer
    Brower, Vicki
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (12): : 835 - 836
  • [33] Reversibility of trastuzumab cardiotoxicity: Is the concept alive and well?
    Ewer, Michael S.
    Tan-Chiu, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (34) : 5532 - 5533
  • [34] Breast Cancer: Cardiotoxicity of Trastuzumab plus Radiotherapy
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (09) : 886 - 886
  • [35] Reversible cardiotoxicity from pegylated liposomal doxorubicin plus trastuzumab (Herceptin): results from 2 prospective studies.
    Kim, E
    Gaiotti, DA
    Volm, MD
    Freedberg, RS
    Muggia, FM
    Vogel, CL
    Panasci, L
    Clemons, M
    Martin, LA
    Chia, SK
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S204 - S204
  • [36] An uncommon cause of reversible tachycardiomyopathy
    Lozano, Daniel Cantero
    Simoni, Favio Rojas
    Fernandez, Javier Garcia
    Gonzalez, Javier Martin
    REVISTA ESPANOLA DE CARDIOLOGIA, 2023, 76 (12): : 1070 - 1070
  • [37] Impact of Trastuzumab-Induced Cardiotoxicity and Subsequent Trastuzumab Interruption on Breast Cancer Outcome
    Yu, Anthony F.
    Yadav, Nandini U.
    Manrique, Carlos R.
    Thaler, Howard T.
    Hudis, Clifford A.
    Dang, Chau T.
    Steingart, Richard M.
    CIRCULATION, 2013, 128 (22)
  • [38] Trastuzumab-related cardiotoxicity in the Herceptin Adjuvant trial
    Montemurro, Filippo
    Redana, Stefania
    Valabrega, Giorgio
    Martinello, Rossella
    Aglietta, Massimo
    Palmiero, Renato
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) : 2052 - 2053
  • [39] Risk factors for trastuzumab cardiotoxicity in a cohort of Mexican population
    Herrera-Martinez, M.
    Miranda-Aguirre, P. A.
    Cota-Apodaca, L. A.
    Martinez-Bustos, V.
    Carbajal-Saldana, B.
    Deneken-Hernandez, Z. C.
    Diaz-Romero, C.
    Namba-Bando, Md M. Y.
    Dominguez-Reyes, C. A.
    Tenorio-Torres, J. A.
    Villegas-Carlos, F.
    Crocco-Quiros, B.
    CANCER RESEARCH, 2019, 79 (04)
  • [40] Concurrent Trastuzumab Use With Radiation Therapy and the Risk for Cardiotoxicity
    Sari, S. Yuce
    Yazici, G.
    Sendur, M. A.
    Altundag, K.
    Gultekin, M.
    Yildiz, F.
    Ozyigit, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E10 - E11
12345